The Department of Veterans Affairs is set to become a back-up health system for those infected by COVID-19. Former Secretary of Veterans Affairs Dr. David Shulkin joins Yahoo Finance’s Zack Guzman and Akiko Fujita on The Ticker to discuss....

Shares of Roche are popping after its coronavirus test received FDA approval. Senior Scholar at John Hopkins Center for Health Security Dr. Amesh Adalja joins Seana Smith on The Ticker to discuss....

As the White house faces pressure to ease the economic impact of the coronavirus, Vice President Pence says private insurers will cover treatment and waive copays for diagnostic tests. Raymond James Healthcare Policy Analyst Chris Meekins joins Yahoo Finance's Seana Smith to discuss....

Visiting Professor at George Washington University School of Public Health, Emergency Physician and Former Baltimore City Health Commissioner Dr. Leana Wen joins Yahoo Finance's Zack Guzman & Brian Cheung, along with Morning Brew Business Editor and Podcast Host Kinsey Grant to discuss the coronavirus outbreak and how the health care sector is responding....

Health officials in Texas are taking action to prevent further spread of the coronavirus. Yahoo Finance's Kristin Myers is on the ground in San Antonio, TX and joins Zack Guzman, Sibile Marcellus and Independent Women's Forum board member & Former Congresswoman Nan Hayworth on YFi PM to discuss....

Some votes are still being counted, but one thing is clear: Super Tuesday provided banner results for former U.S. Vice President Joe Biden's hopes of securing the Democratic presidential nomination.In some prediction markets, Biden's odds have vaulted as high as 85% compared to a meager 10% for...

Health care stocks are losing ground in reaction to Bernie Sanders' rise to Democratic front-runner....

It's not a stretch to say nearly everyone knows that 2020 is a presidential election. The Health Care Select Sector SPDR ETF (XLV) , the largest healthcare ETF by assets, is up an impressive 2.43% year-to-date and investors may want to consider giving the fund another glance despite this being an...

Shares of AbbVie Inc. climbed 2% in premarket trading on Friday although the drugmaker beat earnings expectations for the quarter. The company reported earnings of $2.8 billion, or $1.88 per share, in the fourth quarter of 2019, compared with a loss of $1.8 billion, or $1.23 loss per share, in the same quarter a year ago. Adjusted earnings per share were $2.21 per share, against a FactSet consensus of $2.19. Revenue rose to $8.70 billion for the quarter, up from $8.30 billion in the same period a year ago. The FactSet consensus was $8.69 billion. International sales of Humira, its top-selling rheumatoid arthritis treatment, fell 27% to $948 million, while U.S. sales rose 9.8% to $3.9 billion. The company said that it expects its $63 billion acquisition of Allergan to close this quarter. AbbVie issued strong guidance for 2020 ahead of consensus, saying it expects EPS of $7.66 to $7.76 and adjusted EPS of $9.61 and $9.71. The full-year consensus is $9.45. AbbVie's stock has gained 10% over the past year, compared with the Health Care Select Sector SPDR Fund , which is up 14%....

Democratic presidential hopefuls Pete Buttigieg and Bernie Sanders remain in a tight race in Iowa’s presidential caucuses with 97% of precincts reporting, while the Democratic National Committee’s chairman called for a redo....